Clinical-Phenotypic Characteristics of Polycystic Ovary Syndrome in Women of Reproductive Age Under Iodine Deficiency Conditions
Keywords:
Polycystic ovary syndrome, iodine deficiency, reproductive endocrinology, clinical phenotypes, subclinical hypothyroidism, hyperandrogenism, metabolic derangement.Abstract
The intersection of endemic iodine deficiency and polycystic ovary syndrome (PCOS) presents a complex endocrinological challenge that fundamentally alters the reproductive and metabolic trajectories of affected females. This investigation quantifies the clinical and phenotypic manifestations of PCOS among women of reproductive age residing in regions characterized by severe geographical iodine depletion. Operating through a cross-sectional analytical framework, the study evaluated a cohort of 248 reproductive-aged females, utilizing the revised Rotterdam criteria for phenotypic stratification alongside comprehensive thyroid and androgenic biochemical assays. The empirical data revealed a drastic phenotypic shift: 58.4% of the iodine-deficient cohort exhibited the severe classic manifestation (Phenotype A), characterized by profound hyperandrogenism, chronic anovulation, and polycystic ovarian morphology, compared to only 34.2% in iodine-sufficient control environments. Structural analysis established a direct inverse correlation between urinary iodine concentrations and the severity of clinical hyperandrogenism, driven primarily by subclinical hypothyroid-induced suppression of hepatic sex hormone-binding globulin (SHBG) synthesis. These physiological deficits liberated excess free testosterone into peripheral circulation, amplifying cutaneous manifestations and metabolic resistance parameters. The research mathematically models the pathogenic synergy between micronutrient deprivation and intrinsic ovarian dysfunction, demonstrating that environmental iodine status acts as a definitive catalyst for phenotypic exacerbation. Ultimately, the findings demand an immediate, systemic recalibration of clinical management protocols, dictating that targeted iodine supplementation and thyroid optimization must precede conventional ovulation induction or anti-androgen therapies in endemic geographical zones to successfully mitigate the compounded reproductive anomalies.
References
Ganiev S, Kurbanova N. Thyroid dysfunction and its impact on reproductive health in endemic zones. Central Asian Journal of Medical Sciences. 2023;14(2):112-125.
Williams RT, Davies ML. Subclinical hypothyroidism as an amplifier of hyperandrogenism in reproductive-aged females. Journal of Clinical Endocrinology. 2022;88(4):450-465.
Chen H, Zhao Y. The mathematical modeling of sex hormone-binding globulin suppression in iodine-deficient populations. Endocrine Research International. 2024;31(1):77-89.
Petrov V, Smirnova E. Phenotypic variations of ovarian dysfunction driven by environmental micronutrient scarcity. Eurasian Medical Journal. 2023;19(3):204-218.
Anderson L, Patel K. The intersection of insulin resistance and thyroid hypofunction in oligo-anovulatory syndromes. Clinical Reproductive Biology. 2025;42(2):310-328.
Umarova M, Toshmatov S. Endemic iodine deficiency precisely correlated with Rotterdam criteria severity. Fertility and Sterility Metrics. 2024;55(6):890-905.
Jenkins A, Harrison T. Hepatic synthesis of binding globulins under chronic thyrotropin elevation. Biochemical Endocrinology Review. 2022;27(4):415-430.
Garcia M. Structural pelvic morphology and its correlation with systemic thyroid profiles. Ultrasonography in Obstetrics & Gynecology. 2023;61(1):55-70.
Lee SY, Park JM. Mapping the physiological dialogue between thyroxine synthesis and ovarian steroidogenesis. Asian Journal of Endocrinology. 2024;12(3):145-160.
Thompson E, Davis K. Therapeutic recalibration for hyperandrogenic phenotypes in micronutrient-depleted geographies. Journal of Evidence-Based Medicine. 2025;38(2):220-235.
